Last week, the Coalition for Animal Health, a group of livestock producers, including the National Pork Producers Council, companion-animal-care providers, veterinarians and medicine manufacturers, sent a letter to Congress urging the reauthorization of the Animal Drug Users Act. The law enables the Food and Drug Administration’s Center for Veterinary Medicine to conduct more timely reviews of new animal-health drugs.
When enacted in 2003, ADUFA established performance goals for CVM in exchange for base funds of $43 million over five years, which helped the agency better meet animal health needs by eliminating the extensive backlog of medicine submissions.
NPPC supports CVM and the animal-health industry’s reauthorization proposal, which provides $98 million in fees over the next five years and specifies timelines and improvements to ensure timely decisions on animal medicine submissions. The animal drug review process at FDA is a stringent, science-based process that protects public health by making safe and effective animal-health products available on a timely basis.
Source: National Pork Board